Syndax Price Book Value Ratio from 2010 to 2024
| SNDX Stock | USD 19.30 0.03 0.16% |
Price Book Value Ratio | First Reported 2010-12-31 | Previous Quarter 2.74398753 | Current Value 2.88 | Quarterly Volatility 14.15428118 |
Check Syndax Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syndax Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.4 K, Interest Expense of 197.6 K or Selling General Administrative of 57.1 M, as well as many indicators such as Price To Sales Ratio of 6.97, Dividend Yield of 0.0 or PTB Ratio of 2.88. Syndax financial statements analysis is a perfect complement when working with Syndax Pharmaceuticals Valuation or Volatility modules.
Syndax | Price Book Value Ratio |
Latest Syndax Pharmaceuticals' Price Book Value Ratio Growth Pattern
Below is the plot of the Price Book Value Ratio of Syndax Pharmaceuticals over the last few years. It is Syndax Pharmaceuticals' Price Book Value Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Syndax Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Price Book Value Ratio | 10 Years Trend |
|
Price Book Value Ratio |
| Timeline |
Syndax Price Book Value Ratio Regression Statistics
| Arithmetic Mean | (4.42) | |
| Geometric Mean | 5.50 | |
| Coefficient Of Variation | (320.09) | |
| Mean Deviation | 11.85 | |
| Median | 2.74 | |
| Standard Deviation | 14.15 | |
| Sample Variance | 200.34 | |
| Range | 37.269 | |
| R-Value | 0.71 | |
| Mean Square Error | 105.61 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 2.26 | |
| Total Sum of Squares | 2,805 |
Syndax Price Book Value Ratio History
About Syndax Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Syndax Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Syndax Pharmaceuticals investors use historical funamental indicators, such as Syndax Pharmaceuticals's Price Book Value Ratio, to determine how well the company is positioned to perform in the future. Although Syndax Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Syndax Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Syndax Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Syndax Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Syndax Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price Book Value Ratio | 2.74 | 2.88 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Additional Tools for Syndax Stock Analysis
When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.